1. Home
  2. RCKT vs BAND Comparison

RCKT vs BAND Comparison

Compare RCKT & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • BAND
  • Stock Information
  • Founded
  • RCKT 1999
  • BAND 2000
  • Country
  • RCKT United States
  • BAND United States
  • Employees
  • RCKT N/A
  • BAND N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • BAND Computer Software: Prepackaged Software
  • Sector
  • RCKT Health Care
  • BAND Technology
  • Exchange
  • RCKT Nasdaq
  • BAND Nasdaq
  • Market Cap
  • RCKT 328.6M
  • BAND 431.0M
  • IPO Year
  • RCKT N/A
  • BAND 2017
  • Fundamental
  • Price
  • RCKT $3.28
  • BAND $15.00
  • Analyst Decision
  • RCKT Buy
  • BAND Buy
  • Analyst Count
  • RCKT 13
  • BAND 6
  • Target Price
  • RCKT $12.96
  • BAND $20.80
  • AVG Volume (30 Days)
  • RCKT 6.0M
  • BAND 190.8K
  • Earning Date
  • RCKT 08-07-2025
  • BAND 10-30-2025
  • Dividend Yield
  • RCKT N/A
  • BAND N/A
  • EPS Growth
  • RCKT N/A
  • BAND N/A
  • EPS
  • RCKT N/A
  • BAND N/A
  • Revenue
  • RCKT N/A
  • BAND $758,106,000.00
  • Revenue This Year
  • RCKT N/A
  • BAND $2.48
  • Revenue Next Year
  • RCKT $108.43
  • BAND $13.24
  • P/E Ratio
  • RCKT N/A
  • BAND N/A
  • Revenue Growth
  • RCKT N/A
  • BAND 14.51
  • 52 Week Low
  • RCKT $2.19
  • BAND $11.33
  • 52 Week High
  • RCKT $22.01
  • BAND $23.00
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 51.17
  • BAND 56.17
  • Support Level
  • RCKT $2.88
  • BAND $14.21
  • Resistance Level
  • RCKT $3.74
  • BAND $14.84
  • Average True Range (ATR)
  • RCKT 0.27
  • BAND 0.49
  • MACD
  • RCKT 0.02
  • BAND 0.15
  • Stochastic Oscillator
  • RCKT 35.43
  • BAND 90.04

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

Share on Social Networks: